Actinogen Medical Limited (AU:ACW) has released an update.
Mr. Malcolm McComas, a director of Actinogen Medical Limited, has reported a change in his interest in the company’s securities, specifically the expiry of 3 million unlisted options. The notice to the ASX outlined no acquisition of new securities and confirmed that McComas retains significant holdings, including over 4.5 million fully paid ordinary shares through the Employee Share Plan. This update did not involve any transactions during a closed period requiring prior written clearance.
For further insights into AU:ACW stock, check out TipRanks’ Stock Analysis page.
